Serial measurement of interleukin‐6 and risk of mortality in anticoagulated patients with atrial fibrillation: Insights from ARISTOTLE and RE‐LY trials

Authors:

Abstract
No abstract available
Funding Information
  • Bristol-Myers Squibb
  • Pfizer

This publication has 24 references indexed in Scilit: